EUVIMEDEUVIMED entdecken
Crossref

Amiodarone Association With Severe Primary Graft Dysfunction and Vasoactive Inotropic Score After Heart Transplantation

Natalie S Dorsey, Alec E Biscopink, Brian A Houston, Jessica Atkins, Arman Kilic, Mathew Gregoski, Ryan J Tedford, Jan M Griffin

Journal of Cardiac Failure · 2026

DOI: 10.1016/j.cardfail.2025.05.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026. Verfasst von Natalie S Dorsey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Medical University of South Carolina, Charleston, SC. Hauptthemen laut MEDLINE: Amiodarone, Heart Transplantation, Primary Graft Dysfunction, Anti-Arrhythmia Agents. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The impact of amiodarone on severe primary graft dysfunction (PGD) and vasoactive inotropic scores (VISs) following heart transplantation (HT) is unclear. METHODS AND RESULTS: We investigated these relationships through a retrospective study of 183 consecutive patients >18 years old who underwent isolated HT at our center from 2018-2023. Data for amiodarone use in the 6 months pre-HT were recorded (duration, cumulative dosage, use at HT, last dose pre-HT). Of the 69 patients in the amiodarone cohort, 37 were considered to be taking amiodarone at the time of transplant. The primary endpoint was severe PGD, as defined by the International Society of Heart and Lung Transplantation (ISHLT) criteria. Post-HT VISs were calculated as defined by ISHLT. CONCLUSIONS: Amiodarone was not associated with severe PGD (P = 0.67), and there was no difference in post-transplant VISs based on amiodarone exposure [20 (19.6) vs 16.3 (13.8); P = 0.122] (Fig. 1). This study supports similar hemodynamic profiles post-HT, regardless of amiodarone use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmiodaroneHeart TransplantationPrimary Graft DysfunctionAnti-Arrhythmia AgentsHumansMaleFemaleRetrospective StudiesMiddle AgedAdultSeverity of Illness IndexFollow-Up Studies

Substanzen

AmiodaroneAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Medicine, Medical University of South Carolina, Charleston, SC.
  • Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC.
  • Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC.
  • Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
  • Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC. Electronic address: griffjan@musc.edu.

Zitieren

APA

Dorsey, N. S., Biscopink, A. E., Houston, B. A., Atkins, J., Kilic, A., Gregoski, M., Tedford, R. J., & Griffin, J. M. (2026). Amiodarone Association With Severe Primary Graft Dysfunction and Vasoactive Inotropic Score After Heart Transplantation. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.05.015

Vancouver

Dorsey NS, Biscopink AE, Houston BA, Atkins J, Kilic A, Gregoski M, et al. Amiodarone Association With Severe Primary Graft Dysfunction and Vasoactive Inotropic Score After Heart Transplantation. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2025.05.015

BibTeX
@article{Dorsey2026,
  author = {Dorsey, Natalie S and Biscopink, Alec E and Houston, Brian A and Atkins, Jessica and Kilic, Arman and Gregoski, Mathew and Tedford, Ryan J and Griffin, Jan M},
  title = {Amiodarone Association With Severe Primary Graft Dysfunction and Vasoactive Inotropic Score After Heart Transplantation},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  doi = {10.1016/j.cardfail.2025.05.015}
}
Kostenlos starten →